跳至主要内容
临床试验/KCT0004024
KCT0004024尚未招募未知

An investigator's initiated trial to evaluate the safety of cytokine-induced killers during early transplant period of autologous hematopoeitic stem cell transplant recipients

The Catholic University of Korea, Seoul St. Mary's Hospital0 个研究点目标入组 32 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 70(Year)(—)
性别
All

入选标准

  • 1) Patients between ages 17 and 70 years old
  • 2) Lymphoma patients who are expecting an autologous hematopoeitic stem cell transplantation
  • 3) ECOG performance status 0 or 1
  • 4) Those who are considered to survive longer than 3 months
  • 5) Those without acute infectious disease
  • 6) Those who do not have comorbid tumor
  • 7) Patients who voluntarily signed the informed consent form.

排除标准

  • 1) Pregnant women, lactating women, or women who have the possibility of pregnancy or those who have not taken adequate contraceptive measures
  • 2) Sexually active men who do not take proper contraceptive measures
  • 3) Patients with active infection or fever (=38 ?) with unknown etiology or ongoing bacterial or fungal infections
  • 4) Patients under 19 or over 70 years old
  • 5) ECOG performance status 2, 3, 4
  • 6) Patients with previously proven HIV infection, uncontrolled hypertension (diastolic blood pressure> 115 mmHg), unstable angina, congestive heart failure (NY class II or higher), poorly controlled severe diabetes, coronary angioplasty within 6 months, Patients with acute myocardial infarction or non-malignant disease including uncontrolled atrial or ventricular arrhythmia within the past 6 months
  • 7) Patients with mental illness, drug addiction, etc. who are judged to have an influence on the outcome of the study
  • 8) Patients participating in other clinical trials
  • 9) Patients who are judged to be inadequate for a clinical trial by the principal investigator
  • 10) Other serious medical conditions that may reduce compliance with clinical trials

研究者

发起方
The Catholic University of Korea, Seoul St. Mary's Hospital

相似试验

招募中
2 期
An investigator-initiated trial to investigate the utility of LUNAR-1 in colorectal cancer patients with resectable distant metastasespatients scheduled for curative resection for metastasis of colorectal cancerctDNA, colorectal cancer, oligometastasisD015179
JPRN-jRCT2072220055Oki Eiji160
尚未招募
不适用
A scientific trail to evaluate the effect of a 13 week long lifestyle change program, anchored in the science of yoga i.e Swasth Wellness Program (SWP), on the systolic blood pressure, in subjects who are not on any anti-hypertensive treatment.
CTRI/2021/03/031779Mr Sundeep Kapalia
进行中(未招募)
不适用
The evaluation of safety and efficacy of Sipgeondaebotang in Chronic Fatigue Syndrome
KCT0002684Kyung Hee University Oriental Medicine Hospital at Gangdong96
已完成
1 期
A Phase 1 Investigator Initiated Study to Evaluate the Safety, Tolerability and Preliminary Effectiveness of AB-SA01 in Patients with Chronic Rhinosinusitis Associated with Staphylococcus aureus InfectioInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disordersChronic rhinosinusitis
ACTRN12616000002482The Queen Elizabeth Hospital9
已完成
不适用
Investigator initiated clinical trial to validate usefulness of specific system for endoscopic ultrasound guided hepaticogastrostomy (HG01) in malignant biliary obstructioBiliary obstruction due to unresectable malignant tumorsMalignant biliary obstruction, Endoscopic ultrasound, Biliary drainage, HepatocogastrostomyD001660
JPRN-jRCT2052210020Kitano Masayuki40